Advertisement

Interaktionen und unerwünschte Nebenwirkungen

  • G. Prause

Zusammenfassung

Einteilungen der Antidepressiva können nach ihrer chemischen Struktur, nach pharmakologischem Wirkmechanismus sowie nach klinisch-therapeutischen Wirkprofilen erfolgen. Ältere Einstufungen sprechen von Antidepressiva der 1. (trizyklische Antidepressiva und die irreversiblen MAO-Hemmer), der 2. (neue zyklische Antidepressiva, tetrazyklische Antidepressiva) und der 3. Generation (SSRI = Serotonin-selektive Reuptakeinhibitoren und RIMA = Reversible Inhibitoren der Monoaminooxidase).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bailey RR, Nealte T (1976) Rapid clonidine withdrawal with blood pressure overshoot exaggerated by 13-blockade. Br Med J 1: 942–943PubMedCrossRefGoogle Scholar
  2. Biebuyck J (1991) Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 74: 581–605CrossRefGoogle Scholar
  3. Bloor BC, Flacke WE (1982) Reduction in halothane anesthetic requirement by clonidine, an a-adrenergic agonist. Anesth Analg 61: 741–745PubMedCrossRefGoogle Scholar
  4. Bodem G, Ochs HR (1983) Aktuelle Fragestellungen zur Digitalistherapie. Internist (Berlin) 24: 135–150Google Scholar
  5. Boldt JB, von Bormann B, Kling D, Gorlach G, Hempelmann G (1985) Hämodynamische Effekte unter intravenöser Infusion von Nifedipin bei kardiochirurgischen Patienten. Anästh Intensivther Notfallmed 20: 25–31PubMedCrossRefGoogle Scholar
  6. Bonnet F, Brun-Buisson V, Saada M, Boico M, Rostaing S, Touboul C (1989) Dose related prolongation of hyperbaric tetracaine spinal anesthesia by clonidine in humans. Anesth Analg 68: 619–622PubMedCrossRefGoogle Scholar
  7. Bruce DL, Croley TF, Lee JS (1979) Preoperative clonidine withdrawal syndrom. Anesthesiology 51: 90–92PubMedCrossRefGoogle Scholar
  8. Bühler F (1983) Kalziumantagonisten: Kennt man ein Absetzsyndrom? MMW 125: 14Google Scholar
  9. Couderc E, Ferrier C, Haberer JP, Duvaldestin P (1984) Thiopentone pharmacokinetics in patients with chronic alcoholism. Br J Anaesth 56: 1393–1397PubMedCrossRefGoogle Scholar
  10. Doenicke A (1984) Verunsichert eine Cortisolstory die Anästhesisten? Anaesthesist 33: 391–394PubMedGoogle Scholar
  11. Doenicke A (1985) Nicht nur Etomidat verändert die Cortisolkonzentration. Anaesthesist 34: 138–140Google Scholar
  12. Driessen JJ, Vree TB, Egmond JV, Booij LHD, Crul JF (1984) In vitro interaction of diazepam and oxazepam with pancuronium and suxamethonium. Br J Anaesth 56: 1131–1138PubMedCrossRefGoogle Scholar
  13. El-Ganzouri AR, Ivankovich AD, Braverman B, McCarthy R (1985) Monoamine oxidase inhibitors: should they be discontinued preoperatively? Anesth Analg 64: 592–596PubMedCrossRefGoogle Scholar
  14. Engelman RM, Hadji I, Breyer RH, Whittredge P, Harbison W, Chircop RV (1984) Rebound vaso-spasm after coronar revascularization in association with calcium antagonist withdrawal. Ann Thorac Surg 37: 469–472PubMedCrossRefGoogle Scholar
  15. Foex P (1984) Alpha-and beta-adrenoreceptor antagonists. Br J Anaesth 56: 751–765PubMedCrossRefGoogle Scholar
  16. Forth W, Henschler D, Rummel W, Starke K (1992) Pharmakologie and Toxikologie. BI Wissenschaftsverlag, Mannheim Leipzig Wien ZürichGoogle Scholar
  17. Fragen RJ, Shanks CA, Molteni A, Avram MJ (1984) Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 61: 652–656PubMedCrossRefGoogle Scholar
  18. Freye E (1995) Opioide in der Medizin. Wirkung and Einsatzgebiete zentraler Analgetika, 3. Aufl. Springer, Wien New YorkGoogle Scholar
  19. Gottlieb SO, Gerstenblith G (1985) Safety of acute calcium antagonist withdrawal: studies in patients with unstable angina withdrawn from nifedipin. Am J Cardiol 55: 27E - 30EPubMedCrossRefGoogle Scholar
  20. Hansen D, Fohring, Eyrich K (1990) Antidepressive Dauermedikation–ein erhöhtes Narkoserisiko? Anaesthesist 39 (4): 205–210PubMedGoogle Scholar
  21. Hayashi Y, Maze M (1993) Alpha, Adrenoreceptor agonists and anesthesia. Br J Anaesth 71: 1080–1118CrossRefGoogle Scholar
  22. Henschel F (1990) 30 Jahre Neuroleptanalgesie - Standortbestimmung heute. Anaesthesiol Reanimat 15:267–278Google Scholar
  23. Höfling S, Dworzak H, Butollo W, Neef W (1983) Der Angstprozeß unter verschieden hohen Thalamonaldosen zur Prämedikation. Anaesthesist 32: 512–518PubMedGoogle Scholar
  24. Hong W, Short TG, Hui TWC (1993) Hypnotic and anaesthetic interactions between etamine and midazolam in female patients. Anaesthesiology 79: 1227–1232CrossRefGoogle Scholar
  25. Horan BF, Prys Roberts C, Hamilton WK, Roberts JG (1977) Hemodynamic responses to enflurane anaesthesia and hypovolaemia in the dog and their modification by propranolol. Br J Anaesth 49: 1189–1193PubMedCrossRefGoogle Scholar
  26. Horan BF, Roberts JG, Bennett MJ, Foex P (1977) Hemodynamic responses to isoflurane anaesthesia and hypovolaemia in the dog and their modification by propranolol. Br J Anaesth 49: 1179PubMedCrossRefGoogle Scholar
  27. Hug CC, McLeskey C, Nahrwold M et al. (1993) Hemodynamic effects of propofol. Data from over 25,000 patients. Anesth Analg 77: 21–29Google Scholar
  28. Johnston RR, Eger EI II, Wilson C (1976) A comparative interaction of epinephrine with enflurane, isoflurane and halothane in man. Anesth Analg 55: 709–712PubMedCrossRefGoogle Scholar
  29. Kaplan JA, Dunbar RW (1976) Propranolol and surgical anesthesia. Anesth Analg 55: 1–9PubMedGoogle Scholar
  30. Kazama Tomiei, Ikeda Kazuyuki (1992) The comparative cardiovascular effects of sevoflurane with halothane and isoflurane. J Anesth 2: 63–68Google Scholar
  31. Kopriva CJ, Brown AC, Pappas G (1978) Hemodynamics during general anesthesia in patients receiving propranolol. Anesthesiology 48: 8–34CrossRefGoogle Scholar
  32. Kapur PA, Bloor BC, Flacke WE, Olivine SK (1984) Comparison of cardiovascular responses to verapamil during enflurane, isoflurane and halothane anesthesia in the dog. Anesthesiology 61: 156–160PubMedCrossRefGoogle Scholar
  33. Kates RA, Zaggy AP, Norfleet EA, Heath KR (1984) Comparative cardiovascular effects of verapamil, nifedipin and diltiazem during halothane anesthesia in swine. Anesthesiology 61: 10–18PubMedGoogle Scholar
  34. Kates RA, Kaplan JA, Guyton RA, Dorsey L, Hug CC, Hatcher CR (1983) Hemodynamic interactions of verapamil and isoflurane. Anesthesiology 59: 132–138PubMedCrossRefGoogle Scholar
  35. Kaukinen S, Pyykkö K (1979) The potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol Scand 23: 107–111PubMedCrossRefGoogle Scholar
  36. Kissin I, Jebeles JA (1984) Pentobarbital antagonizes the effect of morphine on cardiac acceleration response to noxious stimulation. Anesth Analg 63: 699–672CrossRefGoogle Scholar
  37. Lauven PM, Stoeckel H, Schüttler J, Schwilden H (1981) Verhinderung des Fentanyl-ReboundPhänomens durch Cimetidin-Medikation. Anaesthesist 30: 467–471PubMedGoogle Scholar
  38. Maslowski AH, Nicholls MG, Ikram H (1981) Haemodynamic, hormonal and electrolyte responses to withdrawal of long-term captopril treatment for heart failure. Lancet 2: 959–961PubMedCrossRefGoogle Scholar
  39. Mclndewar IC, Marshall RJ (1981) Interactions between the neuromuscular blocking drug org NC 45 and some anaesthetic, analgesic and antimicrobial agents. Br J Anaesth 53: 785–791CrossRefGoogle Scholar
  40. Meyers BH, Weis OF, Miller F (1984) Antagonism of diazepam by aminophylline in healthy volunteers. Anesth Analg 63: 900–902Google Scholar
  41. Michaels J, Serrins M, Shier NO, Barash PG (1984) Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors. Anesth Analg 63: 1041–1044PubMedGoogle Scholar
  42. Miller RD, Solm YJ, Matteo RS (1976) Enhancement of d-tubocurarine neuromuscular blockade by diuretics in man. Anesthesiology 45: 442–445PubMedCrossRefGoogle Scholar
  43. Miller RD, Way WL, Eger EL (1968) The effects of et-methyldopa, reserpine, guanethidine and iproniazid on MAC. Anesthesiology 29: 1153–1158PubMedCrossRefGoogle Scholar
  44. Mitterschiffthaler G, Hackl J-M, Neumann R (1989) Malignes Neurolept Syndrom and maligne Hyperthermie. Anaesthesist 38: 210–213PubMedGoogle Scholar
  45. Peters U, Rissler T (1981) Kombinationstherapie von Chinidin and Digitalisglykoside. Dtsch Med Wochenschr 106: 306–309CrossRefGoogle Scholar
  46. Prys Roberts C (1980) Cardiovascular responses to anaesthesia and surgery in patients recieving [3-receptor antagonists. In: Poppers PJ, Van Dijk B (eds) ß-Blockade and anaesthesia. Astra Pharmac, Rijsivijk (Netherlands), pp 164–170Google Scholar
  47. Reyes JG, Kissing I, Fouriner SE, Smith LR (1984) Additive negative inotropic effect of a combination of diazepam and fentanyl. Anesth Analg 63: 97–100Google Scholar
  48. Reyes JG (1984) The relative hemodynamic effects of calcium entryblockers, Anesthesiology 61: 3–5Google Scholar
  49. Riederer P, Laux G, Pöldinger W (Hrsg) (1991–1995) Neuropsychopharmaka - Ein Therapiehandbuch: Bd 2: Tranquilizer and Hypnotika, Bd 3: Antidepressiva and Phasenprophylaktika, Bd 4: Neuroleptika, Bd 5: Parkinsonmittel and Nootropika. Springer, Wien New YorkGoogle Scholar
  50. Sarubin J (1983) Die Häufigkeit von Thrombophlebien nach i.v.-Injektion von Methohexital, Etomidate, Diazepam and Flunitrazepam. Anästh Intensivmed 24: 134–136Google Scholar
  51. Scappaticci KA, Ham JA. Solm YJ, Miller RD, Dretchen KL (1982) Effects of furosemide in the neuromuscular junction. Anesthesiology 57: 381–388PubMedCrossRefGoogle Scholar
  52. Schulte-Sasse U, Hess W, Tarnow J (1982) Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 57: 9–14PubMedCrossRefGoogle Scholar
  53. Scott DB, Buckley FP, Littlewood DG, Macrae WR, Arthur GR, Drumond GB (1978) Circulatory effects of labetalol during halothane anaesthesia. Anaesthesia 33: 145–150PubMedCrossRefGoogle Scholar
  54. Seidl DS, Martin DE (1984) Prolonged bradycardia after neostigmine administration in a patient taking nadolol. Anesth Analg 63: 365–367PubMedCrossRefGoogle Scholar
  55. Sold M, Rothhammer A (1985) Lebensbedrohliche anaphylaktoide Reaktion nach Etomidat. Anaesthesist 34: 208–210PubMedGoogle Scholar
  56. Sollevi A (1992) Adenosine infusion during isoflurane-nitrous oxide anaesthesia: indications of perioperative analgesic effect. Acta Anaesthesiol Scand 36: 595–599PubMedCrossRefGoogle Scholar
  57. Sprague DH (1975) Severe bradycardia after neostigmine in a patient taking propranolol to control paroxysmal atrial tachycardia. Anesthesiology 42: 208–210PubMedCrossRefGoogle Scholar
  58. Sprague DH (1975) Severe bradycardia after neostigmine in a patient taking propranolol to control paroxysmal atrial tachycardia. Anesthesiology 42: 208–210Google Scholar
  59. Stoeckel H, Hengstmann JH, Schüttler J (1979) Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. Br J Anaesth 51: 741–745PubMedCrossRefGoogle Scholar
  60. Stoelting RK (1981) Antihypertensives and alphablockers. In: Smith T, Miller RD, Corbascio AN (eds) Drug interactions in anesthesia. Lea & Febiger. Philadelphia, pp 103–112Google Scholar
  61. Tomichek RC, Rosow CE, Philbin DM, Moss J, Teplick RS, Schneider RC (1983) Diazepamfentanyl interaction: hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg 62: 881–884Google Scholar
  62. Tzeung JT, Wang JJ, Mok MS, Lippmann M (1989) Clonidine potentiates lidocain-induced pidural anesthesia. Anesth Analg 68: 298Google Scholar
  63. Ulsamer B (1988) Vecuroniumbromid: Beeinflussung der Pharmakokinetik durch Etomidat, Cimetidin and Ranitidin. Anesthesist 37: 504–509Google Scholar
  64. Wagner RL, White PF (1984) Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology 61: 647–651PubMedCrossRefGoogle Scholar
  65. Warltier D, Pagel P (1992) Cardiovascular and respiratory actions of desflurane: Is desflurane different from isoflurane? Anesth Analg 75: 17–31Google Scholar
  66. Young L (1992) Effects of desflurane on the central nervous system. Anesth Analg 75: 32–37Google Scholar

Weiterführende Literatur

  1. Boeden G, Schmucker P (1985) Das zentral anticholinerge Syndrom. Anästh Intensivmed 26: 240–248Google Scholar
  2. Bovill JG, Sebel PS, Stanley TH (1984) Opioid analgesics in anesthesia–with special reference to their use in cardiovascular anesthesia. Anesthesiology 61: 731–755PubMedCrossRefGoogle Scholar
  3. Craig DB, Bose D (1984) Drug interactions in anaesthesia: chronic antihypertensive therapy. Can Anaesth Soc J 31: 580–588PubMedCrossRefGoogle Scholar
  4. Cullen BF, Miller MG (1979) Drug interactions and anesthesia: a review. Anesth Analg 58: 413–423PubMedGoogle Scholar
  5. Dudziak R (1980) Droperidol in der modernen Anaesthesiologie und Intensivmedizin. Janssen BroschGoogle Scholar
  6. Dudziak R (1983) Neuroleptanalgesie - Standort und aktuelle Bedeutung einer Anästhesiemethode. Perimed, ErlangenGoogle Scholar
  7. Freye E, Hartung E (1985) Opioide und ihre Antagonisten in der Anästhesiologie. Perimed, ErlangenGoogle Scholar
  8. Gold MS, Lydiard RB, Carmon JS (1984) Advances in psychopharmacology: predicting and improving treatment response. CRC Press, Boca Raton (Florida )Google Scholar
  9. Goodman LS, Gilman A (1984) The pharmacological basis of therapeutics. Macmillan, New YorkGoogle Scholar
  10. Jenkins LC, Scoates PJ (1985) Anaesthetic implications of calcium channel blockers. Can Anaesth Soc J 32: 436–447PubMedCrossRefGoogle Scholar
  11. Kaplan JA (1983) Cardiac anesthesia, vol 2. Grune & Stratton, New York LondonGoogle Scholar
  12. Langrehr D (1985) Benzodiazepine in der Anästhesiologie. Urban & Schwarzenberg, München Wien BaltimoreGoogle Scholar
  13. Lehmann KA (1982) Opiate. Deutsche Akad f Anästh. Fortbildung. Refr Course, Bd 6. Stemmler, Köln, S 20–47Google Scholar
  14. List WF, Gravenstein JS (1965) Atropin und Scopolamin. Anaesthesist 11: 154–157Google Scholar
  15. Mortensen SA (o. J.) Zyklische Antidepressiva und Kardiotoxizität. Organon BroschGoogle Scholar
  16. Orkin FK, Cooperman LH (1983) Complications in anesthesiology. Lippincott, Philadelphia TorontoGoogle Scholar
  17. Prys Roberts C (1984) Anesthesia and hypertension. Br J Anaesth 56: 711–724CrossRefGoogle Scholar
  18. Reyes JG, Kissin I, Lell WA, Tosone S (1982) Calcium entry blockers: uses and implications for anesthesiologists. Anesthesiology 57: 504–518CrossRefGoogle Scholar
  19. Rothammer A, Weis (1982) Lachgas–Wirkungen und Nebenwirkungen. Anästh Intensivmed 23: 237–241Google Scholar
  20. Scholz W (1984) Arzneimittelwechselwirkungen. Scholz-Liste. Thieme, Stuttgart New YorkGoogle Scholar
  21. Selvin BL (1981) Cancer chemotherapy: implications for the anesthesiologist. Anesth Analg 60: 425–433PubMedCrossRefGoogle Scholar
  22. Smith T, Miller RD, Corbascio AN (1981) Drug interactions in anesthesia. Lea &Febiger, PhiladelphiaGoogle Scholar
  23. Sorkin EM, Darvey DL (1983) Review of cimetidine drug interactions. Drug Intell Clin Pharm 17: 110–120PubMedGoogle Scholar
  24. Stirt JA, Sullivan SF (1981) Aminophylline. Anesth Analg 60: 587–602Google Scholar
  25. Stöckel H (1982) Das zentral-anticholinergische Syndrom - Physostigmin in der Anästhesiologie und Intensivmedizin. INA, Bd 35. Thieme, Stuttgart New YorkGoogle Scholar
  26. White PF, Way WL, Trevor AJ (1982) Ketamine–its pharmacology and therapeutic uses. Anesthesiology 56: 119–136PubMedCrossRefGoogle Scholar
  27. Williams JG (1983) H-Receptor antagonists and anaesthesia. Can Anaesth Soc J 30: 264–269PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • G. Prause

There are no affiliations available

Personalised recommendations